These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7440763)

  • 1. Uricosuric effect of fenofibrate in healthy volunteers.
    Desager JP; Hulhoven R; Harvengt C
    J Clin Pharmacol; 1980 Oct; 20(10):560-4. PubMed ID: 7440763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzbromarone and fenofibrate are lipid lowering and uricosuric: a possible key to metabolic syndrome?
    Gresser U; Gathof BS; Gross M
    Adv Exp Med Biol; 1994; 370():87-90. PubMed ID: 7661033
    [No Abstract]   [Full Text] [Related]  

  • 3. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of benzbromarone on the renal excretion of allantoin in normouricemic and hyperuricemic humans (author's transl)].
    Janzen D; Mertz DP; Scheiffele E; Kühnhold O
    Klin Wochenschr; 1977 Nov; 55(21):1071-3. PubMed ID: 926719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fenofibrate on uric acid metabolism and urate transporter 1.
    Uetake D; Ohno I; Ichida K; Yamaguchi Y; Saikawa H; Endou H; Hosoya T
    Intern Med; 2010; 49(2):89-94. PubMed ID: 20075570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people.
    Ansquer JC; Dalton RN; Caussé E; Crimet D; Le Malicot K; Foucher C
    Am J Kidney Dis; 2008 Jun; 51(6):904-13. PubMed ID: 18501783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
    Harvengt C; Heller F; Desager JP
    Artery; 1980; 7(1):73-82. PubMed ID: 7247733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of hypouricemic effect of benzbromarone.
    Sinclair DS; Fox IH
    J Rheumatol; 1975 Dec; 2(4):437-45. PubMed ID: 1206675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study.
    Zürcher RM; Bock HA; Thiel G
    Nephrol Dial Transplant; 1994; 9(5):548-51. PubMed ID: 8090336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fenofibrate in combination with urate lowering agents in patients with gout.
    Lee YH; Lee CH; Lee J
    Korean J Intern Med; 2006 Jun; 21(2):89-93. PubMed ID: 16913436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
    Ahn SO; Ohtomo S; Kiyokawa J; Nakagawa T; Yamane M; Lee KJ; Kim KH; Kim BH; Tanaka J; Kawabe Y; Horiba N
    J Pharmacol Exp Ther; 2016 Apr; 357(1):157-66. PubMed ID: 26907620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of allopurinol and benzbromarone on the concentration of uridine in plasma.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
    Metabolism; 1997 Dec; 46(12):1473-6. PubMed ID: 9439546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of allopurinol and oxipurinol after chronic oral administration. Interaction with benzbromarone.
    Colin JN; Farinotti R; Fredj G; Tod M; Clavel JP; Vignon E; Dietlin F
    Eur J Clin Pharmacol; 1986; 31(1):53-8. PubMed ID: 3780828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of benzbromarone: a new uricosuric drug.
    Sorensen LB; Levinson DJ
    Arthritis Rheum; 1976; 19(2):183-90. PubMed ID: 1259799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial.
    Bastow MD; Durrington PN; Ishola M
    Metabolism; 1988 Mar; 37(3):217-20. PubMed ID: 3278190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.
    Iwanaga T; Kobayashi D; Hirayama M; Maeda T; Tamai I
    Drug Metab Dispos; 2005 Dec; 33(12):1791-5. PubMed ID: 16135657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone.
    Walter-Sack I; de Vries JX; Ittensohn A; Kohlmeier M; Weber E
    Klin Wochenschr; 1988 Feb; 66(4):160-6. PubMed ID: 3374026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
    Kamilli I; Gresser U; Pellkofer T; Löffler W; Zöllner N
    Z Rheumatol; 1989; 48(6):307-12. PubMed ID: 2623976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.